A Systematic Review of Cost-Effectiveness Studies of Newer Non-Insulin Antidiabetic Drugs: Trends in Decision-Analytical Models for Modelling of Type 2 Diabetes Mellitus

BACKGROUND: We performed a systematic overview of the cost-effectiveness analyses (CEAs) comparing Non-insulin antidiabetic drugs (NIADs) with other NIADs for the treatment of type 2 diabetes mellitus (T2DM), using decision-analytical modelling (DAM), focusing on both the economic results and the un...

Descripción completa

Detalles Bibliográficos
Autores principales: Laursen, Henrik Vitus Bering, Jørgensen, Emmelie Ploug, Vestergaard, Peter, Ehlers, Lars Holger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570198/
https://www.ncbi.nlm.nih.gov/pubmed/37410277
http://dx.doi.org/10.1007/s40273-023-01268-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570198/
https://www.ncbi.nlm.nih.gov/pubmed/37410277
http://dx.doi.org/10.1007/s40273-023-01268-5

Ejemplares similares